Nisa Investment Advisors’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding EWTX
PCM
SAM
QPW
Nisa Investment Advisors's EWTX Position: Q2 2026 in Review
Nisa Investment Advisors reduced its Edgewise Therapeutics (EWTX) stake by 27% in Q2 2026, selling an estimated $15.8K and leaving 1,218 shares worth $49.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1858.
Nisa Investment Advisors first reported a position in EWTX in Q3 2021 and has held it in 17 quarters since. The position peaked at $178K in Q3 2022. 68 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.
- Nisa Investment Advisors held 1,218 shares of Edgewise Therapeutics worth $49.5K as of Q2 2026.
- Nisa Investment Advisors sold 459 Edgewise Therapeutics shares in Q2 2026, an estimated $15.8K.
- Edgewise Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1858 holding.
- Nisa Investment Advisors first reported a position in Edgewise Therapeutics in Q3 2021 and has held it in 17 quarters since.
- Nisa Investment Advisors's Edgewise Therapeutics position peaked at $178K in Q3 2022.
- 68 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.